Treatment of seborrhoeic dermatitis with a cream containing furalglucitole;Trattamento della dermatite seborroica con una crema contenente furalglucitolo

Annali Italiani di Dermatologia Clinica e Sperimentale

Volumn 50, Issue 3, 1996, Pages 148-150

  Vena, Gino Antonio ^a   Coviello, Carmela ^a   Loconsole, Francesco ^a   Cassano, Nicoletta ^a   Foti, Caterina ^a   Mastrolonardo, Mario ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

antioxidant antiinflammatory treatment; furalglucitole; seborrhoeic dermatitis

Indexed keywords

ALLANTOIN; ANTIOXIDANT; FURALGLUCITOLE; GLYCYRRHETINIC ACID; LICHTENA AI; SORBITOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEBORRHEIC DERMATITIS; TOPICAL DRUG ADMINISTRATION;

EID: 0029833587     PISSN: 0365169X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Passi S. Biochemical aspects of seborrhoeic dermatitis. In: Ippolito F (ed). Proceedings of symposium on seborrhoeic dermatitis. Rome, 17 april 1993. Boll Ist Dermatol S. Gallicano 1994; XIV: 19.
2. Passi S, Morrone A, De Luca C, et al. Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrheic dermatitis. J Dermatol Sci 1991; 2: 171.
3. Arletti R, Bernardi M, Poggioli R. Influenza del 2,4-monofurfurilindentetra-o-metil sorbitolo (MSF) su alcuni effetti tossici della metil-β-cloroetilamina nel ratto. Riv Farmacol Terap 1972; 3: 49.
4. Zanoli P. Mechanism of protection with 2,4-monofurfurilindentetra-o-metil-sorbitolo (MSF) against acute toxicity due to Amanita phalloides toxicity in mice. Arzneim-Forsch 1979; 29: 1885.
5. Garzia A, Zanoli P. Inibizione con 2,4-monofurfurilindentetra-o-metil-sorbitolo (MSF) dell'ossidazione in vitro della cisteina. Riv Farmacol Ter 1981; XII: 153.
6. Infante JP. Vitamin E and selenium participation in fatty acid desaturation: a proposal for an enzymatic function of these nutrients. Molec Cell Biochem 1986; 69: 93.
7. Caprilli F. The role of Pityrosporum in seborrhoeic dermatitis. In: Ippolito F (ed). Proceedings of symposium on seborrhoeic dermatitis. Rome. 17 april 1993. Boll Ist Dermatol S. Gallicano 1994; XIV: 9.
8. Balus L. Histopatology. In: Ippolito F (ed). Proceedings of symposium on seborrhoeic dermatitis. Rome, 17 april 1993. Boll Ist Dermatol S. Gallicano 1994; XIV: 29.
9. Fabbri P, Geti V. Dermatite seborroica: aspetti immunologici. Micol Dermatol 1991; 5: 55.
10. Mathes BM, Douglas MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985; 13: 947.
11. Fuchs J. Oxidative injury in dermatopathology. Berlin: Springer-Verlag, 1992.
12. Winrow VR, Winyard PG, Morris CJ, et al. Free radicals in inflammation: second messangers and mediators of tissue destruction. Br Med Bull 1993; 49: 506.
13. Darr D, Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol 1994; 102: 671.
14. Brenner RR. Nutritional and ormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1982; 20: 41